Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2024

Regulatory News:

Median Technologies (Paris:ALMDT):

Total number of shares

18,448,233

Number of real voting rights*
(excluding treasury shares**)

18,363,983

Theoretical number of voting rights*
(including treasury shares**)

18,425,033

(*) Class E preference shares are non-voting

(**) pursuant to article 223-11 of the AMF’s General Regulations

About Median Technologies: Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240906061455/en/

The Median Technologies Stock at the time of publication of the news with a fall of -11,89 % to 5,185EUR on Lang & Schwarz stock exchange (06. September 2024, 17:46 Uhr).